Mcl-1 stabilization confers resistance to taxol in human gastric cancer

Wu Shuang1, Lili Hou2, Yan Zhu3

  • 1Department of Immunology, Anhui Medical University, Hefei, China.

Oncotarget
|November 16, 2017
PubMed

Insights

Upregulation of Myeloid cell leukemia-1 (Mcl-1) causes acquired Taxol resistance in gastric cancer by stabilizing Mcl-1 via the PI3K/Akt pathway. Inhibiting Mcl-1 or PI3K/Akt reverses this resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Taxol is a key antineoplastic drug for gastric cancer.
  • Acquired Taxol resistance limits its therapeutic effectiveness.
  • Understanding resistance mechanisms is crucial for developing new treatments.

Purpose of the Study:

  • To identify mechanisms of acquired Taxol resistance in human gastric cancer.
  • To investigate the role of Myeloid cell leukemia-1 (Mcl-1) in Taxol resistance.
  • To explore the involvement of the PI3K/Akt signaling pathway.

Main Methods:

  • Investigated Mcl-1 expression and stability in Taxol-resistant gastric cancer cells.
  • Analyzed the activation status of the PI3K/Akt signaling pathway.
  • Assessed the effects of Mcl-1 and PI3K/Akt inhibition on Taxol resistance.

Main Results:

  • Upregulation and stabilization of Mcl-1 were observed in Taxol-resistant cells.
  • Hyper-activation of the PI3K/Akt pathway was linked to Mcl-1 stabilization.
  • Increased Mcl-1 inhibited Taxol-induced apoptosis by preventing mitochondrial outer membrane permeabilization.
  • Inhibition of Mcl-1 or PI3K/Akt reversed the Taxol-resistant phenotype.

Conclusions:

  • Mcl-1 upregulation, driven by PI3K/Akt hyper-activation, confers acquired Taxol resistance in gastric cancer.
  • Mcl-1 acts by blocking Taxol-induced apoptosis.
  • The PI3K/Akt pathway is a critical regulator of Taxol acquired resistance.
  • Mcl-1 represents a potential therapeutic target for overcoming Taxol resistance in gastric cancer.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.8K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K